204 related articles for article (PubMed ID: 34078404)
1. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.
An HS; Kim GB; Song MK; Lee SY; Kwon HW; Lee JW; Bae EJ
Pediatr Rheumatol Online J; 2021 Jun; 19(1):78. PubMed ID: 34078404
[TBL] [Abstract][Full Text] [Related]
2. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
3. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
Zhang H; Zhang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):461-468. PubMed ID: 38802905
[TBL] [Abstract][Full Text] [Related]
4. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
[TBL] [Abstract][Full Text] [Related]
5. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
6. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S; Zhang H; Zhang R; Tang M; Luo E; Yang Y; Gao Y; Yue S; Liang H; Cai J
J Pediatr (Rio J); 2023; 99(4):406-412. PubMed ID: 36977496
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for coronary artery lesions in children with Kawasaki disease.
Duan J; Jiang H; Lu M
Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
[TBL] [Abstract][Full Text] [Related]
10. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
11. Association between maternal age and outcomes in Kawasaki disease patients.
Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
[TBL] [Abstract][Full Text] [Related]
12. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
15. Intravenous gamma-globulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
[TBL] [Abstract][Full Text] [Related]
17. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
Duan C; Du ZD; Wang Y; Jia LQ
World J Pediatr; 2014 Aug; 10(3):232-7. PubMed ID: 25124974
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.
La Vecchia A; Stracquadaino R; Mauri L; Baselli LA; Abdallah R; Cucchetti M; Colli AM; Agostoni C; Dellepiane RM
BMC Pediatr; 2024 Feb; 24(1):139. PubMed ID: 38395821
[TBL] [Abstract][Full Text] [Related]
19. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of recurrent Kawasaki disease and its risk factors.
Yang HM; Du ZD; Fu PP
Eur J Pediatr; 2013 Dec; 172(12):1641-7. PubMed ID: 23887608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]